Heart Rate Variability as an Alternative Indicator for Identifying Cardiac Iron Status in Non-Transfusion Dependent Thalassemia Patients

被引:18
|
作者
Wijarnpreecha, Karn [1 ,2 ,3 ]
Siri-Angkul, Natthaphat [1 ,2 ,3 ]
Shinlapawittayatorn, Krekwit [1 ,2 ,3 ]
Charoenkwan, Pimlak [3 ,4 ]
Silvilairat, Suchaya [3 ,4 ]
Siwasomboon, Chate [5 ]
Visarutratna, Pannee [5 ]
Srichairatanakool, Somdet [6 ]
Tantiworawit, Adisak [7 ]
Phrommintikul, Arintaya [7 ]
Chattipakorn, Siriporn C. [1 ,3 ,8 ]
Chattipakorn, Nipon [1 ,2 ,3 ]
机构
[1] Chiang Mai Univ, Fac Med, Cardiac Electrophysiol Res & Training Ctr, Chiang Mai 50000, Thailand
[2] Chiang Mai Univ, Fac Med, Dept Physiol, Cardiac Electrophysiol Unit, Chiang Mai 50000, Thailand
[3] Chiang Mai Univ, Ctr Excellence Cardiac Elect, Chiang Mai 50000, Thailand
[4] Chiang Mai Univ, Fac Med, Dept Pediat, Chiang Mai 50000, Thailand
[5] Chiang Mai Univ, Fac Med, Dept Radiol, Chiang Mai 50000, Thailand
[6] Chiang Mai Univ, Fac Med, Dept Biochem, Chiang Mai 50000, Thailand
[7] Chiang Mai Univ, Fac Med, Dept Internal Med, Chiang Mai 50000, Thailand
[8] Chiang Mai Univ, Fac Med, Dept Oral Biol & Diagnost Sci, Chiang Mai 50000, Thailand
来源
PLOS ONE | 2015年 / 10卷 / 06期
关键词
TRANSFERRIN-BOUND IRON; LABILE PLASMA IRON; OXIDATIVE STRESS; OVERLOAD CARDIOMYOPATHY; MAGNETIC-RESONANCE; CHELATION-THERAPY; SERUM FERRITIN; RISK; PATHOPHYSIOLOGY; METABOLISM;
D O I
10.1371/journal.pone.0130837
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Iron-overload cardiomyopathy is a major cause of death in thalassemia patients due to the lack of an early detection strategy. Although cardiac magnetic resonance (CMR) T2* is used for early detection of cardiac iron accumulation, its availability is limited. Heart rate variability (HRV) has been used to evaluate cardiac autonomic function and found to be depressed in thalassemia. However, its direct correlation with cardiac iron accumulation has never been investigated. We investigated whether HRV can be used as an alternative indicator for early identification of cardiac iron deposition in thalassemia patients. Methods Ninety-nine non-transfusion dependent thalassemia patients (23.00 (17.00, 32.75) years, 35 male) were enrolled. The correlation between HRV recorded using 24-hour Holter monitoring and non-transferrin bound iron (NTBI), hemoglobin (Hb), serum ferritin, LV ejection fraction (LVEF), and CMR-T2* were determined. Results The median NTBI value was 3.15 (1.11, 6.59) mu M. Both time and frequency domains of HRV showed a significant correlation with the NTBI level, supporting HRV as a marker of iron overload. Moreover, the LF/HF ratio showed a significant correlation with CMR-T2* with the receiver operating characteristic (ROC) curve of 0.684 +/- 0.063, suggesting that it could represent the cardiac iron deposit in thalassemia patients. HRV was also significantly correlated with serum ferritin and Hb. Conclusions This novel finding regarding the correlation between HRV and CMR-T2* indicates that HRV could be a potential marker in identifying early cardiac iron deposition prior to the development of LV dysfunction, and may be used as an alternative to CMR-T2* for screening cardiac iron status in thalassemia patients.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Study on the Clinico-Haematological Profile of Patients of Non-Transfusion Dependent Thalassemia (NTDT) Attending Thalassemia Clinic at a Tertiary Care Hospital
    Das, Indrani
    Sengupta, Ananya
    Chakrabarti, Abhishek
    Kargupta, Arindam
    Roy, Krishnendu
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2020, 9 (18): : 1475 - 1479
  • [22] Concurrent Treatment with Minhepcidin and Deferiprone Improves Anemia and Enhances Reduction of Spleen Iron in a Mouse Model of Non-Transfusion Dependent Thalassemia
    Casu, Carla
    Oikonomidau, Rea
    Shah, Yatrik
    Nemeth, Elizabeta
    Ganz, Tomas
    MacDonald, Brian
    Rivella, Stefano
    BLOOD, 2014, 124 (21)
  • [23] Correcting Non-Transfusion Dependent β-Thalassemia by Utilizing a Combined Therapy that Modulates FPO Activity by Limiting Erythroid Cellular Iron Intake
    Casu, Carla
    Lo Presti, Vania
    Aghajan, Mariam
    Liu, Alison
    Munoz, Kevin A.
    O'Hara, Emir
    Neil, Garry
    Miari, Reem
    Domev, Hagit
    Shapir, Nir
    Guo, Shuling
    Rivella, Stefano
    BLOOD, 2018, 132
  • [24] Measurement of Liver Iron Concentration in a Population of Non-Transfusion Dependent Thalassemia Patients Using a Trained Artificial Neural Network to Analyse Magnetic Resonance Images
    St Pierre, Tim
    Cooper, Tony
    Nguyen Ngoc Trang
    Nguyen Thi Thu Ha
    Dang Thai Ton
    Nguyen Khoi Viet
    Pham Minh Thong
    Nguyen Anh Tri
    Bach Quoc Khanh
    Boulos, Sherif
    House, Michael
    Pang, Wenjie
    Bangma, Sander
    Taher, Ali
    BLOOD, 2017, 130
  • [25] Heart Rate Variability for Early Detection of Iron Overload Cardiomyopathy in β-Thalassemia Patients
    Koonrungsesomboon, Nut
    Tantiworawit, Adisak
    Phrommintikul, Arintaya
    Saekho, Suwit
    Srichairattanakool, Somdet
    Chattipakorn, Nipon
    HEMOGLOBIN, 2015, 39 (04) : 281 - 286
  • [26] LUSPATERCEPT INCREASES HEMOGLOBIN, REDUCES LIVER IRON CONCENTRATION, AND IMPROVES QUALITY OF LIFE IN NON-TRANSFUSION DEPENDENT ADULTS WITH BETA-THALASSEMIA
    Piga, A.
    Perrotta, S.
    Melpignano, A.
    Borgna-Pignatti, C.
    Gamberini, M. R.
    Voskaridou, E.
    Caruso, V.
    Ricchi, P.
    Pietrangelo, A.
    Zhang, X.
    Wilson, D.
    Bellevue, A.
    Laadem, A.
    Sherman, M.
    Attie, K.
    HAEMATOLOGICA, 2016, 101 : 304 - 304
  • [27] MRI PROSPECTIVE SURVEY ON CARDIAC IRON AND FUNCTION AND ON HEPATIC IRON IN NON TRANSFUSION-DEPENDENT THALASSEMIA INTERMEDIA PATIENTS TREATED WITH DESFERRIOXAMINE OR NON CHELATED
    Meloni, A.
    Ricchi, P.
    Maddaloni, D.
    Rosso, R.
    Benni, M.
    Salvatori, C.
    Restaino, G.
    Vallone, A.
    Positano, V.
    Pepe, A.
    HAEMATOLOGICA, 2016, 101 : 851 - 852
  • [28] Erythropoiesis and Iron Homeostasis in Non-Transfusion-Dependent Thalassemia Patients with Extramedullary Hematopoiesis
    Huang, Yumei
    Liu, Rongrong
    Wei, Xiaoyun
    Liu, Jiaodi
    Pan, Lingyuan
    Yang, Gaohui
    Lai, Yongrong
    BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [29] MRI prospective survey on cardiac iron and function and on hepatic iron in non transfusion-dependent thalassemia intermedia patients treated with desferrioxamine or non chelated
    Pepe, A.
    Giuliano, P.
    Renne, S.
    Ricchi, P.
    Errigo, C.
    Cavalli, P.
    De Marchi, D.
    Missere, M.
    Vinci, V.
    Grassedonio, E.
    Positano, V.
    Meloni, A.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1254 - 1254
  • [30] Durable Symptom Improvement for Patients with Non-Transfusion Dependent Thalassemia Treated with Luspatercept: Patient-Reported Outcomes from the BEYOND Study
    Musallam, Khaled M.
    Taher, Ali T.
    Kattamis, Antonis
    Cappellini, Maria Domenica
    Lord-Bessen, Jennifer
    Glassberg, Mrudula
    Pelligra, Christopher
    Guo, Shien
    Medlin, Loyse Felber
    Bueno, Luciana Moro
    Kuo, Kevin H. M.
    BLOOD, 2023, 142